Venus Medtech (Hangzhou), Inc. Class H Financial Overview
Venus Medtech (Hangzhou), Inc. Class H's market cap is currently HK$1.09B. The company's EPS TTM is HK$-0.34151688469999997; its P/E ratio is -1.55; Venus Medtech (Hangzhou), Inc. Class H is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
